drugset / Trial / NCT00555035
GSK1349572 First Time in Human Study
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine safety, tolerability and pharmacokinetics of GSK1349572
Timeline
- Start
- 2007-11
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dolutegravir | Other / unclassified | — | — |
Indications
No indication recorded.